Tower Research Capital »

China Sxt Pharmaceuticals In shares owned by Tower Research Capital

Quarter-by-quarter ownership of China Sxt Pharmaceuticals In (SXTC) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in China Sxt Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including China Sxt Pharmaceuticals In held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in China Sxt Pharmaceuticals In by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.5k 2.9k 1.57
2025-06-30 $261 151 1.73

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding China Sxt Pharmaceuticals In

Invesco
Geode Capital Management
Citadel Advisors
Renaissance Technologies
Virtu Financial
Hrt Financial
Two Sigma Securities
Tower Research Capital
UBS Group
State of Wyoming

View all funds holding China Sxt Pharmaceuticals In